These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 38188193)

  • 21. The Therapeutic Potential and Usage Patterns of Cannabinoids in People with Spinal Cord Injuries: A Systematic Review.
    Nabata KJ; Tse EK; Nightingale TE; Lee AHX; Eng JJ; Querée M; Walter M; Krassioukov AV
    Curr Neuropharmacol; 2021; 19(3):402-432. PubMed ID: 32310048
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Using remotely delivered Spring Forest Qigong™ to reduce neuropathic pain in adults with spinal cord injury: A non-randomized controlled trial.
    Van de Winckel A; Carpentier ST; Deng W; Zhang L; Philippus A; Monden KR; Battaglino R; Morse LR
    medRxiv; 2023 Feb; ():. PubMed ID: 36824929
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Feasibility of using remotely delivered Spring Forest Qigong to reduce neuropathic pain in adults with spinal cord injury: a pilot study.
    Van de Winckel A; Carpentier ST; Deng W; Zhang L; Philippus A; Battaglino R; Morse LR
    Front Physiol; 2023; 14():1222616. PubMed ID: 37719467
    [No Abstract]   [Full Text] [Related]  

  • 24. Cannabis for Chronic Pain: A Rapid Systematic Review of Randomized Control Trials.
    Longo R; Oudshoorn A; Befus D
    Pain Manag Nurs; 2021 Apr; 22(2):141-149. PubMed ID: 33353819
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeting the endocannabinoid system for management of HIV-associated neuropathic pain: A systematic review.
    Aly E; Masocha W
    IBRO Neurosci Rep; 2021 Jun; 10():109-118. PubMed ID: 34179865
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of Patient Education on Reducing Medication in Spinal Cord Injury Patients With Neuropathic Pain.
    Shin JC; Kim NY; Chang SH; Lee JJ; Park HK
    Ann Rehabil Med; 2017 Aug; 41(4):621-630. PubMed ID: 28971047
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Understanding Cannabis-Based Therapeutics in Sports Medicine.
    Maurer GE; Mathews NM; Schleich KT; Slayman TG; Marcussen BL
    Sports Health; 2020; 12(6):540-546. PubMed ID: 32936058
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cannabinoids as pharmacotherapies for neuropathic pain: from the bench to the bedside.
    Rahn EJ; Hohmann AG
    Neurotherapeutics; 2009 Oct; 6(4):713-37. PubMed ID: 19789075
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cannabis-based medicines--GW pharmaceuticals: high CBD, high THC, medicinal cannabis--GW pharmaceuticals, THC:CBD.
    Drugs R D; 2003; 4(5):306-9. PubMed ID: 12952500
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Utilization of medicinal cannabis for pain by individuals with spinal cord injury.
    Stillman M; Capron M; Mallow M; Ransom T; Gustafson K; Bell A; Graves D
    Spinal Cord Ser Cases; 2019; 5():66. PubMed ID: 31632724
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Kratom Alkaloids, Cannabinoids, and Chronic Pain: Basis of Potential Utility and Role in Therapy.
    Farkas DJ; Cooper ZD; Heydari LN; Hughes AC; Rawls SM; Ward SJ
    Cannabis Cannabinoid Res; 2023 Jul; ():. PubMed ID: 37466474
    [No Abstract]   [Full Text] [Related]  

  • 32. Cannabis and Neuropsychiatric Disorders: An Updated Review.
    Chayasirisobhon S
    Acta Neurol Taiwan; 2019 Jun; 28(2)():27-39. PubMed ID: 31867704
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Nutritional Supplement as Adjuvant of Gabapentinoids for Adults with Neuropathic Pain following Spinal Cord Injury and Stroke: Preliminary Results.
    Raffaeli W; Felzani G; Tenti M; Greco L; D'Eramo MP; Proietti S; Morone G
    Healthcare (Basel); 2023 Sep; 11(18):. PubMed ID: 37761760
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chronic neuropathic pain management in spinal cord injury patients. What is the efficacy of pharmacological treatments with a general mode of administration? (oral, transdermal, intravenous).
    Attal N; Mazaltarine G; Perrouin-Verbe B; Albert T;
    Ann Phys Rehabil Med; 2009 Mar; 52(2):124-41. PubMed ID: 19909703
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatments that are perceived to be helpful for non-neuropathic pain after traumatic spinal cord injury: a multicenter cross-sectional survey.
    Tsai CY; Bryce TN; Delgado AD; Mulroy S; Maclntyre B; Charlifue S; Felix ER
    Spinal Cord; 2021 May; 59(5):520-528. PubMed ID: 33742116
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuropathic pain post spinal cord injury part 2: systematic review of dorsal root entry zone procedure.
    Mehta S; Orenczuk K; McIntyre A; Willems G; Wolfe DL; Hsieh JT; Short C; Loh E; Teasell RW;
    Top Spinal Cord Inj Rehabil; 2013; 19(1):78-86. PubMed ID: 23678288
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Herbal medicinal products or preparations for neuropathic pain.
    Boyd A; Bleakley C; Hurley DA; Gill C; Hannon-Fletcher M; Bell P; McDonough S
    Cochrane Database Syst Rev; 2019 Apr; 4(4):CD010528. PubMed ID: 30938843
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gabapentin is a first line drug for the treatment of neuropathic pain in spinal cord injury.
    Levendoglu F; Ogün CO; Ozerbil O; Ogün TC; Ugurlu H
    Spine (Phila Pa 1976); 2004 Apr; 29(7):743-51. PubMed ID: 15087796
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.